Table 1.
Characteristics of patients with NVG
| Injection Group | Control Group | P | |
|---|---|---|---|
| Total Patients | 21 | 22 | |
| Gender | 0.45 | ||
| Male | 10 | 13 | |
| Female | 11 | 9 | |
| Age | 60.1 ± 13.8 (32–81) | 58.6 ± 17.3 (28–81) | 0.76 |
| Diagnosis | 0.90 | ||
| CRVO | 8 | 7 | |
| BRVO | 2 | 2 | |
| DR | 11 | 13 | |
| Baseline IOP (mm Hg) | 46.4 ± 13.3 (24.5–76.0) | 45.0 ± 14.9 (23.5–78.5) | 0.74 |
| Prior intravitreal injection | 0 | 0 | |
| NVI/NVA Degree | 0.90 | ||
| NVI only | 3 | 2 | |
| NVI&NVA (Open-angle) | 5 | 4 | |
| NVI&NVA (partial Closed-angle) | 2 | 3 | |
| NVI&NVA (Closed-angle) | 11 | 13 | |
| PRP before | 0.55 | ||
| none | 12 | 9 | |
| Incomplete | 6 | 8 | |
| complete | 3 | 5 | |
| BCVA (LogMAR) | 1.1 ± 0.4 (0.3–1.6) | 1.2 ± 0.4 (0.4–1.6) | 0.65 |
| Pre-medications | 2.5 ± 0.5 (2–3) | 2.6 ± 0.5 (2–3) | 0.66 |
Note: The difference in gender was compared between the two groups using the chi-square test, the difference in NVI/NVA degree was compared using two-tailed Fisher’s exact test, and the differences in diagnosis and PRP before were compared using the corrected chi-square test. Differences in age, IOP, BCVA and anti-glaucoma medications were compared using the t test